Savant Capital, LLC Eli Lilly & CO Transaction History

Savant Capital, LLC

$11.7 Billion
Q3 2024

A detailed history of Savant Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Savant Capital, LLC holds 53,000 shares of LLY stock, worth $39.6 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

53,000

Previous 41,497 27.72%

Holding current value

$39.6 Million

Previous $37.6 Million 24.98%

% of portfolio

0.4%

Previous 0.37%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $8.88 Million - $11 Million	11,503 Added 27.72%	53,000 $47 Million
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $1.05 Million - $1.32 Million	-1,454 Reduced 3.39%	41,497 $37.6 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $770,452 - $1.03 Million	1,301 Added 3.12%	42,951 $33.4 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $501,031 - $590,650	-954 Reduced 2.24%	41,650 $24.3 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $431,222 - $594,505	-992 Reduced 2.28%	42,604 $22.9 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $1.08 Million - $1.45 Million	3,082 Added 7.61%	43,596 $20.4 Million
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $1.37 Million - $1.61 Million	4,423 Added 12.26%	40,514 $13.9 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $308,688 - $359,683	960 Added 2.73%	36,091 $13.2 Million
Q3 2022 Oct 28, 2022	BUY	$296.48 - $337.87 $171,958 - $195,964	580 Added 1.68%	35,131 $11.4 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $235,248 - $276,215	844 Added 2.5%	34,551 $11.2 Million
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $484,165 - $601,694	2,063 Added 6.52%	33,707 $9.65 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $72,626 - $90,129	323 Added 1.03%	31,644 $8.74 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $4.31 Million - $5.3 Million	19,435 Added 163.51%	31,321 $7.24 Million
Q2 2021 Aug 04, 2021	SELL	$180.55 - $233.54 $59,220 - $76,601	-328 Reduced 2.69%	11,886 $2.73 Million
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $19,554 - $25,313	119 Added 0.98%	12,214 $2.28 Million
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $84,668 - $112,036	649 Added 5.67%	12,095 $2.04 Million
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $18,569 - $21,479	127 Added 1.12%	11,446 $1.69 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $112,682 - $135,612	826 Added 7.87%	11,319 $1.86 Million
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $125,716 - $155,601	1,056 Added 11.19%	10,493 $1.46 Million
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $748 - $927	-7 Reduced 0.07%	9,437 $1.24 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $11,426 - $12,429	-107 Reduced 1.12%	9,444 $1.06 Million
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $60,048 - $70,091	-542 Reduced 5.37%	9,551 $1.06 Million
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $8,125 - $9,564	73 Added 0.73%	10,093 $1.31 Million
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $243,887 - $273,227	2,303 Added 29.84%	10,020 $1.16 Million
Q3 2018 Oct 23, 2018	BUY	$85.86 - $107.31 $12,277 - $15,345	143 Added 1.89%	7,717 $828,000
Q2 2018 Aug 07, 2018	SELL	$75.7 - $86.88 $4,542 - $5,212	-60 Reduced 0.79%	7,574 $646,000
Q1 2018 Apr 27, 2018	BUY	$74.21 - $87.6 $3,710 - $4,380	50 Added 0.66%	7,634 $591,000
Q4 2017 Jan 31, 2018	BUY	$81.94 - $87.89 $20,157 - $21,620	246 Added 3.35%	7,584 $641,000
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $565,539 - $627,692	7,338	7,338 $628,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Account

Savant Capital, LLC Eli Lilly & CO Transaction History